Key facts
- It has raised $1.0M; the latest was Seed Round ($1.0M) in Nov 2025.
- Notable investors include Foxmont Capital Partners.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Eluvo
- ·The full record, as it builds
Funding rounds
No funding rounds for Eluvo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Eluvo
Provider of women's health care services intended to address reproductive and hormonal health needs. The company offers comprehensive medical care, including fertility, maternal health, hormone management, menopause support, and telehealth services, enabling women to access specialized care at various life stages through both in-person clinics and digital platforms.
- Sector
- Healthcare
- HQ
- Parañaque, Philippines
- Founded
- 2023
- Employees
- 7
- Website
- eluvohealth.com/
- Ownership
- Privately Held (backing)
Eluvo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Eluvo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Eluvo in its N-PORT filings yet. We sweep new filings monthly.